IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

DAVID J NEIDHARDT

Allopathic & Osteopathic Physicians Family Medicine

NPI
1396797510
CMS profile
154300
Location
LIMA, OH

General Payments · PY2018–2024

$231,138.64

  • Reported across 563 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$34,022.86

69 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Family Medicine OH All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $33,187.46 20
Food and Beverage $756.34 48
Travel and Lodging $79.06 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Takeda Pharmaceuticals U.S.A., Inc. $33,266.52 21
ABBVIE INC. $173.02 14
PFIZER INC. $87.21 5
Acerta Pharma LLC $83.00 5
Boehringer Ingelheim Pharmaceuticals, Inc. $78.10 5
Radius Health, Inc. $49.12 3
Lilly USA, LLC $47.98 3
Amgen Inc. $38.87 2
Salix Pharmaceuticals, a division of Bausch Health US, LLC $37.07 2
GlaxoSmithKline, LLC. $28.61 2
Mylan Specialty L.P. $28.49 1
Actelion Pharmaceuticals US, Inc. $23.49 1
Phathom Pharmaceuticals, Inc. $20.15 1
AIMMUNE THERAPEUTICS, INC. $16.38 1
Esperion Therapeutics, Inc. $15.83 1
Sumitomo Pharma America, Inc. $15.45 1
Astellas Pharma US Inc $13.57 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $21,600.65 78
PY2019 $32,214.61 81
PY2020 $25,600.64 68
PY2021 $45,157.56 92
PY2022 $42,453.35 94
PY2023 $30,088.97 81
PY2024 $34,022.86 69

Payment records · PY2024 (69)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $8.00 01/23/2024 Food and Beverage Undisputed 01/23/2026 1105108680 CMS
ABBVIE INC. $16.15 03/05/2024 Food and Beverage Undisputed 01/23/2026 1105108682 CMS
ABBVIE INC. $15.86 03/22/2024 Food and Beverage Undisputed 01/23/2026 1105108684 CMS
ABBVIE INC. $7.42 04/11/2024 Food and Beverage Undisputed 01/23/2026 1105108686 CMS
ABBVIE INC. $14.35 04/17/2024 Food and Beverage Undisputed 01/23/2026 1105108688 CMS
ABBVIE INC. $13.97 04/30/2024 Food and Beverage Undisputed 01/23/2026 1105108690 CMS
ABBVIE INC. $7.39 06/05/2024 Food and Beverage Undisputed 01/23/2026 1105108692 CMS
ABBVIE INC. $6.89 06/21/2024 Food and Beverage Undisputed 01/23/2026 1105108694 CMS
ABBVIE INC. $18.98 07/19/2024 Food and Beverage Undisputed 01/23/2026 1105108696 CMS
ABBVIE INC. $12.51 07/26/2024 Food and Beverage Undisputed 01/23/2026 1105108698 CMS
ABBVIE INC. $6.40 08/01/2024 Food and Beverage Undisputed 01/23/2026 1105108700 CMS
ABBVIE INC. $10.83 08/02/2024 Food and Beverage Undisputed 01/23/2026 1105108702 CMS
ABBVIE INC. $21.35 09/20/2024 Food and Beverage Undisputed 01/23/2026 1105108704 CMS
ABBVIE INC. $12.92 11/01/2024 Food and Beverage Undisputed 01/23/2026 1105108706 CMS
Actelion Pharmaceuticals US, Inc. $23.49 05/24/2024 Food and Beverage Undisputed 01/23/2026 1078907109 CMS
AIMMUNE THERAPEUTICS, INC. $16.38 08/23/2024 Food and Beverage Undisputed 01/23/2026 1147010292 CMS
Amgen Inc. $21.45 06/25/2024 Food and Beverage Undisputed 01/23/2026 1111660873 CMS
Amgen Inc. $17.42 10/22/2024 Food and Beverage Undisputed 01/23/2026 1111660875 CMS
Astellas Pharma US Inc $13.57 06/07/2024 Food and Beverage Undisputed 01/23/2026 1139356873 CMS
AstraZeneca Pharmaceuticals LP $16.74 07/30/2024 Food and Beverage Undisputed 01/23/2026 1104500166 CMS
AstraZeneca Pharmaceuticals LP $23.59 08/13/2024 Food and Beverage Undisputed 01/23/2026 1105489567 CMS
AstraZeneca Pharmaceuticals LP $14.57 08/27/2024 Food and Beverage Undisputed 01/23/2026 1105736479 CMS
AstraZeneca Pharmaceuticals LP $14.05 09/24/2024 Food and Beverage Undisputed 01/23/2026 1104709141 CMS
AstraZeneca Pharmaceuticals LP $14.05 10/29/2024 Food and Beverage Undisputed 01/23/2026 1105260007 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $17.36 02/20/2024 Food and Beverage Undisputed 01/23/2026 1117994170 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $16.58 03/12/2024 Food and Beverage Undisputed 01/23/2026 1117994168 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $15.33 05/16/2024 Food and Beverage Undisputed 01/23/2026 1117994166 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $14.89 06/04/2024 Food and Beverage Undisputed 01/23/2026 1117994164 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $13.94 09/17/2024 Food and Beverage Undisputed 01/23/2026 1117994162 CMS
Esperion Therapeutics, Inc. $15.83 08/09/2024 Food and Beverage Undisputed 01/23/2026 1129448500 CMS
GlaxoSmithKline, LLC. $13.20 10/25/2024 Food and Beverage Undisputed 01/23/2026 1116492419 CMS
GlaxoSmithKline, LLC. $15.41 11/21/2024 Food and Beverage Undisputed 01/23/2026 1116550723 CMS
Lilly USA, LLC $17.42 03/01/2024 Food and Beverage Undisputed 01/23/2026 1136131330 CMS
Lilly USA, LLC $14.67 09/10/2024 Food and Beverage Undisputed 01/23/2026 1136131332 CMS
Lilly USA, LLC $15.89 11/12/2024 Food and Beverage Undisputed 01/23/2026 1136131328 CMS
Mylan Specialty L.P. $28.49 12/27/2024 Food and Beverage Undisputed 01/23/2026 1147370692 CMS
PFIZER INC. $17.67 03/20/2024 Food and Beverage Undisputed 01/23/2026 1132028547 CMS
PFIZER INC. $20.85 03/26/2024 Food and Beverage Undisputed 01/23/2026 1131264796 CMS
PFIZER INC. $16.83 04/09/2024 Food and Beverage Undisputed 01/23/2026 1131408592 CMS
PFIZER INC. $18.71 09/27/2024 Food and Beverage Undisputed 01/23/2026 1132026931 CMS
PFIZER INC. $13.15 12/04/2024 Food and Beverage Undisputed 01/23/2026 1131123304 CMS
Phathom Pharmaceuticals, Inc. $20.15 08/05/2024 Food and Beverage Undisputed 01/23/2026 1151101761 CMS
Radius Health, Inc. $19.18 01/05/2024 Food and Beverage Undisputed 01/23/2026 1089946246 CMS
Radius Health, Inc. $14.64 04/27/2024 Food and Beverage Undisputed 01/23/2026 1089946251 CMS
Radius Health, Inc. $15.30 11/05/2024 Food and Beverage Undisputed 01/23/2026 1089946258 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $22.41 04/17/2024 Food and Beverage Undisputed 01/23/2026 1153688976 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $14.66 12/23/2024 Food and Beverage Undisputed 01/23/2026 1153615384 CMS
Sumitomo Pharma America, Inc. $15.45 11/19/2024 Food and Beverage Undisputed 01/23/2026 1148895633 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,500.00 01/10/2024 Consulting Fee Undisputed 01/23/2026 1137642464 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,200.00 01/17/2024 Consulting Fee Undisputed 01/23/2026 1137642466 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,200.00 02/14/2024 Consulting Fee Undisputed 01/23/2026 1137642468 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,078.17 03/11/2024 Consulting Fee Undisputed 01/23/2026 1137642470 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,009.29 04/17/2024 Consulting Fee Undisputed 01/23/2026 1137642472 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,200.00 05/10/2024 Consulting Fee Undisputed 01/23/2026 1137642474 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,000.00 06/05/2024 Consulting Fee Undisputed 01/23/2026 1137642476 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,200.00 06/10/2024 Consulting Fee Undisputed 01/23/2026 1137642478 CMS
Takeda Pharmaceuticals U.S.A., Inc. $500.00 06/24/2024 Consulting Fee Undisputed 01/23/2026 1137642480 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,500.00 07/03/2024 Consulting Fee Undisputed 01/23/2026 1137642482 CMS
Takeda Pharmaceuticals U.S.A., Inc. $79.06 07/03/2024 Travel and Lodging Undisputed 01/23/2026 1137642484 CMS
Takeda Pharmaceuticals U.S.A., Inc. $550.00 07/03/2024 Consulting Fee Undisputed 01/23/2026 1137642486 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,500.00 07/12/2024 Consulting Fee Undisputed 01/23/2026 1137642488 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,200.00 07/12/2024 Consulting Fee Undisputed 01/23/2026 1137642490 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,200.00 08/09/2024 Consulting Fee Undisputed 01/23/2026 1137642492 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,200.00 09/11/2024 Consulting Fee Undisputed 01/23/2026 1137642494 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,100.00 09/13/2024 Consulting Fee Undisputed 01/23/2026 1137642496 CMS
Takeda Pharmaceuticals U.S.A., Inc. $550.00 10/02/2024 Consulting Fee Undisputed 01/23/2026 1137642498 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,200.00 10/09/2024 Consulting Fee Undisputed 01/23/2026 1137642500 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,200.00 11/13/2024 Consulting Fee Undisputed 01/23/2026 1137642502 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,100.00 12/16/2024 Consulting Fee Undisputed 01/23/2026 1137642504 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.